SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-20-009703
Filing Date
2020-04-24
Accepted
2020-04-24 16:30:29
Documents
4
Period of Report
2020-06-18
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A nc10007781x1_def14a.htm DEF 14A 660510
2 nc10007781x1_neosx1.jpg GRAPHIC 150544
3 nc10007781x1_pc01.jpg GRAPHIC 438907
4 nc10007781x1_pc02.jpg GRAPHIC 345338
  Complete submission text file 0001140361-20-009703.txt   1948304
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38470 | Film No.: 20815472
SIC: 2834 Pharmaceutical Preparations